Eisai Co., Ltd.
Eisai Co., Ltd. (ESAIY) Financial Performance & Income Statement Overview
Analyze Eisai Co., Ltd. (ESAIY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Eisai Co., Ltd. (ESAIY) Income Statement & Financial Overview
Explore comprehensive income reports for Eisai Co., Ltd. ESAIY, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $188.24B | $216.14B | $195.99B | $189.03B |
| Cost of Revenue | $40.60B | $45.94B | $42.51B | $39.76B |
| Gross Profit | $147.63B | $170.21B | $153.48B | $149.27B |
| Gross Profit Ratio | $0.78 | $0.79 | $0.78 | $0.79 |
| R&D Expenses | $46.31B | $43.56B | $40.03B | $41.74B |
| SG&A Expenses | $106.51B | $104.52B | $97.42B | $99.54B |
| Operating Expenses | $152.82B | $142.64B | $142.86B | $135.87B |
| Total Costs & Expenses | $193.42B | $188.58B | $185.37B | $175.62B |
| Interest Income | $2.09B | $2.76B | $2.07B | $3.28B |
| Interest Expense | $1.09B | $777.00M | $937.00M | $715.00M |
| Depreciation & Amortization | $9.83B | $10.04B | $9.97B | $10.06B |
| EBITDA | $10.90B | $41.34B | $24.40B | $26.75B |
| EBITDA Ratio | $0.06 | $0.19 | $0.12 | $0.14 |
| Operating Income | -$5.18B | $27.57B | $10.62B | $13.41B |
| Operating Income Ratio | -$0.03 | $0.13 | $0.05 | $0.07 |
| Other Income/Expenses (Net) | $5.16B | $1.99B | $4.94B | $2.56B |
| Income Before Tax | -$21.00M | $29.55B | $15.57B | $15.97B |
| Income Before Tax Ratio | -$0.00 | $0.14 | $0.08 | $0.08 |
| Income Tax Expense | -$627.00M | $5.16B | $4.01B | $4.46B |
| Net Income | $949.00M | $23.79B | $11.11B | $10.58B |
| Net Income Ratio | $0.005 | $0.11 | $0.06 | $0.06 |
| EPS | $3.36 | $84.31 | $39.19 | $36.95 |
| Diluted EPS | $3.36 | $84.31 | $39.19 | $36.95 |
| Weighted Avg Shares Outstanding | $282.05M | $282.19M | $283.53M | $286.35M |
| Weighted Avg Shares Outstanding (Diluted) | $282.05M | $282.19M | $283.53M | $286.35M |
Financial performance has remained strong, with revenue growing from $189.03B in Q1 2024 to $188.24B in Q4 2024. Gross profit continued to perform well, with margins at 78% in the latest quarter. Operating income reached -$5.18B in Q4 2024, holding a steady -3% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $10.90B. Net income dropped to $949.00M, keeping EPS at $3.36. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan